Shareholder tax
47. When a special distribution is made from
a with-profits fund, the firm incurs a corporation tax liability
(at a rate of 28%) on the share of profits attributable to shareholders.[90]
Some, but not all, life firms are permitted to charge this tax
liability to their inherited estate, prior to the distribution,
thus reducing the size of the distribution to policyholders, or,
alternatively, the size of the residual inherited estate.
48. Which? said that "effectively, they
[life firms] are using money which would have gone to policyholders
to pay the shareholders' tax bill".[91]
Which? reported that policyholders gained less than 90% of the
special distribution announced by Norwich Union in February 2008
as a result of the shareholder tax rule: "In addition to
the £230 million payment to shareholders, an additional shareholder
tax bill of £40 million will be charged to the inherited
estate. The equivalent gross split between policyholders and shareholders
might be equivalent to 88:12, rather than the 90:10, which is
required by the policyholder's contract".[92]
Norwich Union disputed that the effect of charging shareholder
tax to the inherited estate was to subsidise the insurer's corporate
activity or the shareholder's return. Instead, they argued, it
was "to ensure that the insurance company's shareholders
actually receive their 10% share of distributions".[93]
49. The FSA prohibits companies from charging
shareholder tax to the inherited estate, unless it was the firm's
established practice to do so, and the practice was disclosed
in the firm's Principles and Practices of Financial Management
(PPFM) document.[94]
In explaining why the FSA had different rules for different companies,
Mr Sants, the FSA's Chief Executive, acknowledged that this was
a "tricky question", but defended the FSA's position
as the right judgement "in the round". He argued that
it would be wrong to disallow the charging of shareholder tax
for those firms that currently do so, because this would constitute
retrospective regulation:
We absolutely acknowledge here we have an approach for those who have already declared it is custom and practice and for those who do not have it as custom and practice.
This is clearly a difficult judgment. I absolutely respect that
there are different views that could be taken on this. We tried
to make a judgment in the round. I would come back to the general
comments I have made about the fact that we are trying to make
judgments in the round. We are also recognising that as a regulator
we try not to make retrospective judgments. That is another good
principle of regulation, you do not act retrospectively unreasonably.
It is in that context we have reached the view that we have reached
on tax.[95]
The FSA described its decision to permit those firms
already charging shareholder tax to the estate to continue doing
so as a "concession" in a 2004 consultation paper.[96]
Which? argued that the FSA's position was "utterly illogical":
If something is wrong, and they [the FSA] believe
now, it seems, that it is wrong because they are not allowing
people to do it, then [allowing] people to do it because they
have done it in the past strikes me as a curious twist of logic.
If it is wrong, it should not be allowed. If it is right, it should
be allowed and it should be allowed for everybody; some people
should not be treated differently from others.[97]
Ms Spottiswoode supported the view that the charging
of shareholder tax was either appropriate, or it was notit
could not be both.[98]
She was opposed to the use of inherited estate to pay shareholder
tax and urged the FSA to consult on the issue.[99]
50. The charging of shareholder tax to the
inherited estate is, in our view, a striking example of how certain
life firms are able to use their discretion in a way that furthers
shareholder interest to the detriment of policyholders. This tax
liability is only incurred as a result of shareholder involvement
in the with-profits fund (no such liability would arise in a mutual
fund, for example), so it seems unfair that policyholders should
pay anything towards this charge. It would seem that the FSA shares
our view, given that firms in general are disallowed from charging
the estate shareholder tax, unless they have been doing it in
the past. In the case of the charging of shareholder tax to inherited
estate, different rules apply to different firms, providing yet
more complexity. We believe consistency in regulation is paramount.
We urge the FSA to consult on the charging of shareholder tax
to the inherited estate by the end of 2008. Our view is that it
should not be permitted.
27